Brad Rees
Presidente presso G2 Therapies Pty Ltd.
Posizioni attive di Brad Rees
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
G2 Therapies Pty Ltd.
 G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Presidente | - | - |
Storia della carriera di Brad Rees
Precedenti posizioni note di Brad Rees
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Goldman Sachs & Partners (Australia) Pty Ltd. | Presidente | - | 01/01/2007 |
The Garvan Institute of Medical Research
 The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Direttore/Membro del Consiglio | 22/06/2011 | - |
Statistiche
Distribuzione geografica
| Australia | 4 |
Posizioni
| Director/Board Member | 1 |
| President | 1 |
| Chairman | 1 |
Settori
| Commercial Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
| Goldman Sachs & Partners (Australia) Pty Ltd. | Finance |
G2 Therapies Pty Ltd.
G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Health Technology |
- Borsa valori
- Insiders
- Brad Rees
- Esperienza
